ADVERTISEMENT
Sun Pharma — Positive On Specialty Portfolio Ramp-Up In The U.S., Continued Growth In India: Nirmal Bang
Scaling up of the global specialty portfolio would remain the key focus area with Ilumya, Winlevi, Cequa being main growth drivers
14 Jun 2023, 02:45 PM IST 
Save
Finished tablets cascade down the channels of a packaging machine at Sun Pharmaceutical Industries Ltd. (Source: Company website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
